Back to Search Start Over

Tetra Pharm Technologies and Glysious Announce Collaboration to Develop Transdermal Combination Drugs Targeting the Endocannabinoid System

Source :
Obesity, Fitness & Wellness Week. May 11, 2024, 49
Publication Year :
2024

Abstract

2024 MAY 11 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration [...]

Subjects

Subjects :
Health products industry -- Alliances and partnerships -- Product development
Transdermal medication -- Product development
Pharmaceutical industry -- Alliances and partnerships -- Product development
Cooperative agreement for product development
Health

Details

Language :
English
ISSN :
15316386
Database :
Gale General OneFile
Journal :
Obesity, Fitness & Wellness Week
Publication Type :
Periodical
Accession number :
edsgcl.792698454

Tools

Authors Abstract Subjects Details